Humacyte Inc share price logo

Humacyte Inc Share Price

NASDAQ: HUMA

Small Cap

$1.53

-0.04

(-2.23%)

as on

Humacyte Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.52
    $1.62
    downward going graph

    0.65%

    Downside

    5.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.15
    $6.77
    downward going graph

    24.84%

    Downside

    342.48%

    Upside

    downward going graph

Humacyte Inc share price movements today

Previous Close
$1.57
Open
$1.57
Volume
2.1M
Day's Low - High
$1.52 - $1.62
52 Week Low - High
$1.15 - $6.77

Humacyte Inc Historical Returns

1 Month Return
-15 %
3 Month Return
-35.17 %
1 Year Return
-71.35 %
3 Year Return
-61.27 %
5 Year Return
0 %

Humacyte Inc Stock Fundamentals & Key Indicators

Check Humacyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$249.4M

EPS (TTM)

-0.419

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.28

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-103.9M

Revenue (TTM)

818.0K

Profit Margin

0.00%

Return On Equity TTM

6397900.00%

Humacyte Inc Stock Valuation

Track how Humacyte Inc P/E has moved over time to understand its valuation trends.

Humacyte Inc in the last 5 years

  • Overview

  • Trends

Lowest (11.98x)

September 30, 2022

Industry (0.00x)

September 18, 2025

Today (-8.28x)

September 18, 2025

Highest (11.98x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.28x

Humacyte Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Humacyte Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$249.4MNA-8.280.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Humacyte Inc Stock including INR - Dollar returns

The Humacyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Humacyte Inc investment value today

Current value as on today

₹33,250

Returns

₹66,750

(-66.75%)

Returns from Humacyte Inc Stock

₹71,348 (-71.35%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Humacyte Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Humacyte Inc. Average target price of $8.43

Humacyte Inc Share Price Target

Get share price movements and forecasts by analysts on Humacyte Inc.

What analysts predicted

81.85%UPSIDE

Target Price

$8.43

Current Price

$1.53

Analyzed by

12 Analysts

Target

$8.43

Humacyte Inc target price $8.43, a slight upside of 81.85% compared to current price of $1.53. According to 12 analysts rating.

Humacyte Inc Stock's Interest Amongst Investors

Search interest for Humacyte Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Humacyte Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
10
-
-
-
7
0
0
Gross Profit
-2
-1
-1
-3
-1
-1
-1
3
-1
0
Operating Income
-22
-26
-24
-26
-26
-29
-30
-28
-23
-29
EBITDA
-33
-19
-23
-20
-28
-52
-34
-16
43
-29
Interest Expense
1
1
1
1
1
2
2
2
3
2
Depreciation
2
1
1
1
1
1
1
1
1
1
Income Before Tax
-36
-22
-25
-25
-31
-56
-39
-20
39
-37
Income Tax Expense
24
1
1
-28
1
-
-
-1
-
-
Net Income
-61
-22
-25
-25
-31
-56
-39
-20
39
-37
Net Profit Margin
0.00%
0.00%
0.00%
-232.68%
0.00%
0.00%
0.00%
-289.71%
7570.41%
-12510.96%

Humacyte Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
6
1
1
1
-
-
Gross Profit
-69
-6
-60
-6
-76
-7
Operating Income
-85
-64
-81
-84
-100
-114
EBITDA
-78
-56
-72
-76
-96
-132
Interest Expense
2
2
4
6
6
9
Depreciation
-
8
8
8
8
7
Income Before Tax
-85
-66
-26
-11
-110
-148
Income Tax Expense
-
2
-64
-76
3
-
Net Income
-85
-66
-26
-11
-110
-148
Net Profit Margin
-1380.67%
-4461.70%
-2096.36%
-764.54%
0.00%
0.00%

Humacyte Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-22
-25
-25
-31
-56
-39
-20
39
-37
Operating Cash Flow
-22
-13
-19
-27
-21
-22
-26
-28
-26
Investing Cash Flow
1
0
0
0
0
0
0
0
0
Financing Cash Flow
6
0
0
62
0
0
51
46
2
Change in Cash
-14
-14
-19
34
-21
-22
24
17
-24

Humacyte Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-66
-26
-11
-110
-148
Operating Cash Flow
-55
-81
-71
-73
-98
Investing Cash Flow
0
-8
4
0
-1
Financing Cash Flow
2
266
-1
4
114
Change in Cash
-53
177
-67
-68
14

Global Institutional Holdings in Humacyte Inc

Funds
Holdings
BlackRock Inc
5.3%
Vanguard Group Inc
4.25%
State Street Corp
2.75%
Heights Capital Management Inc
2.59%
Woodline Partners LP
2.55%

Insights on Humacyte Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 172.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 139.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HUMA stock has moved down by -15.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 10.79M → 301.0K (in $), with an average decrease of 55.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 39.13M → -37.65M (in $), with an average decrease of 196.2% per quarter

About Humacyte Inc

biotechnology company
OrganisationHumacyte Inc
Headquarters2525 East North Carolina Highway 54, Durham, NC, United States, 27713
IndustryHealthcare
CEODr. Laura E. Niklason M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Humacyte Inc

Name

Title

Dr. Heather Connelly Ph.D.

Senior Vice President of Quality

Dr. Laura E. Niklason M.D., Ph.D.

Founder, President, CEO & Director

Mr. Dale A. Sander

CFO, Chief Corporate Development Officer & Treasurer

Ms. Sabrina Osborne GPHR, SPHR

Chief People Officer

Mr. William John Scheessele

Chief Commercial Officer

Dr. Shamik J. Parikh M.D.

Chief Medical Officer

Dr. Yang Cao M.D., Ph.D.

Chief Regulatory Officer

Ms. Lisa Molyneux

Executive Vice President of Enterprise Planning & Analysis

FAQs

What is Humacyte Inc share price today?

Humacyte Inc share price today is $1.53 as on at the close of the market. Humacyte Inc share today touched a day high of $1.62 and a low of $1.52.

What is the 52 week high and 52 week low for Humacyte Inc share?

Humacyte Inc share touched a 52 week high of $6.77 on and a 52 week low of $1.15 on . Humacyte Inc stock price today i.e. is closed at $1.53,which is 77.40% down from its 52 week high and 33.04% up from its 52 week low.

What is Humacyte Inc's market capitalisation today?

Humacyte Inc market capitalisation is $0.00T as on .

How to invest in Humacyte Inc Stock (HUMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Humacyte Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Humacyte Inc Shares that will get you 0.9804 shares as per Humacyte Inc share price of $1.53 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Humacyte Inc Stock (HUMA) from India?

Indian investors can start investing in Humacyte Inc (HUMA) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Humacyte Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Humacyte Inc share’s latest price of $1.53 as on September 18, 2025 at 1:29 am IST, you will get 6.5359 shares of Humacyte Inc. Learn more about fractional shares .